We don’t actually make a profit or a loss on shares until we sell. When a share price rises or falls we make so-called paper losses or paper gains. In my case, the gains and losses are recorded on a spreadsheet.  The loss I made on Carillion recently was a real loss because the company went into liquidation but most losses are paper losses and the share often recovers. Immupharma plunged over 70% this week and that wiped over 20% off my portfolio and far more from my expected return. It was a major blow, so what can I do now? I just have to see it in context and do more research. The results of their pivotal phase three trial weren’t as good as expected and the price plunged by over £1.00 a share. I have read the results of the trial and I think, as someone who suffers from lupus, that the drug still has a lot of potentials and so does the company. The share price has recovered a little since Tuesday.

Read the rest of this page »